EGFR and lung adenocarcinoma: Lee et al. 14 reported 71 stage IV lung adenocarcinoma patients, finding SUVmax of metastasis (both nodal and distant) was a significant independent predictor of EGFR mutations, meanwhile SUVmax of primary tumor wasn't significant.